Imagine spending thousands of dollars on weight-loss medication—only to discover months later that it doesn't work for your ...

The Medicare GLP-1 Bridge may hold the key to Eli Lilly's market share.

Medicare's new GLP-1 Bridge program offers eligible beneficiaries Wegovy, Zepbound, or Foundayo for $50 a month starting July ...

Penn Holderness, a family influencer, has the highest genetic risk for Alzheimer's. He started taking a GLP-1 solely to prevent it, but experts say the research is still emerging.

Ozempic was supposed to be a gut story. Then Allison Shapiro looked at the brain scans. An assistant professor at the University of Colorado Anschutz, she was part of a team studying 13 teens and ...

The story of GLP-1 drugs keeps getting bigger. First they transformed the treatment of diabetes. Then they upended the science — and culture — of weight loss. Now a growing body of research is raising ...

The enormous popularity of new weight-loss drugs often eclipses the downsides: the burden of weekly injections, rough gastrointestinal side effects, muscle and bone loss. That is shaping a race among ...